Effect of interstitial and/or systemic delivery of tirapazamine on the radiosensitivity of human glioblastoma multiforme in nude mice

Radiation Oncology Investigations

Volumn 6, Issue 2, 1998, Pages 63-70

  Cardinale, Robert M ^a   Dillehay, Larry E ^a,b   Williams, Jeffery A ^a   Tabassi, Kevin ^a   Brem, Henry ^a   Lee, Ding Jen ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Glioblastoma multiforme; Hypoxic cell cytotoxin; Implantable polymer disc; Tirapazamine (SR 4233)

Indexed keywords

TIRAPAZAMINE;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; GLIOBLASTOMA; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RADIOSENSITIVITY; TREATMENT OUTCOME;

ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; GLIOBLASTOMA; HUMANS; MALE; MICE; MICE, NUDE; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS; TRIAZINES;

EID: 0031924291     PISSN: 10657541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6823(1998)6:2<63::AID-ROI1>3.0.CO;2-F     Document Type: Article

References (38)

1. Walker MD, Green SB, Byar DP, Alexander E, Batzdorf U, Brooks WH, Hunt WE, MacCarty S, Mahalay S, Owens G, Ransohoff J, Robertson JT, Shapiro WR, Smith KR, Wilson CB, Strike TA: Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303:1323-1329, 1980.
2. Kornblith PL, Walker M: Chemotherapy for malignant gliomas. J Neurosurg 68:1-17, 1988.
3. Salazar OM, Rubin P, Feldstein ML, Pizzutiello R: High dose radiation therapy in the treatment of malignant gliomas; final report. Int J Radiat Oncol Biol Phys 3:1733-1740, 1979.
4. Kayama T, Yoshimoto T, Fujimoto S, Sakurai Y: Intratumoral oxygen pressure in malignant brain tumors. J Neurosurg 74:55-59, 1991.
5. Rampling R, Cruickshank G, Lewis AD, Fitzsimmons S, Workman P: Direct measurement of pO2 distribution and bioreductive enzymes in human malignant brain tumors. Int J Radiat Oncol Biol Phys 29:427-431, 1994.
6. Valk PE, Mathis CA, Prados MD, Gilbert JC, Budinger TF: Hypoxia in human gliomas: demonstration by PET with flourine-18-fluoromisonidazole. J Nucl Med 33: 2133-2137, 1992.
7. Gatenby RA, Kessler HB, Rosenblum SJ, Cola RL, Moldofsky PJ, Wartz WH, Broder GJ: Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int J Radiat Oncol Biol Phys 14:831-838, 1988.
8. Brown JM, Lemmon MJ: Potentiation by the hypoxic cytotoxin SR 4233 of cell killing produced by fractionated irradiation of mouse tumors. Cancer Res 50:7745-7749, 1990.
9. Brown JM, Lemmon MJ: SR 4233: A tumor specific radiosensitizer active in fractionated radiation regimens. Radiother Oncol 20:151-156, 1991.
10. Brown JM, Giaccia AJ: Tumor hypoxia: The picture has changed in the 1990s. Int J Radiat Biol 65:95-102, 1994.
11. Brown JM, Koong A: Therapeutic advantage of hypoxic cells in tumors: A theoretical study. J Natl Cancer Inst 83:178-185, 1991.
12. Brem H: Polymers to treat brain tumors. Biomaterials 11:699-710, 1990.
13. Brem H, Tamargo RJ, Olivi A, Finn M, Wingard JD, Wharam M: Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain. J Neurosurg 80:283-290, 1994.
14. Tamargo RJ, Myseros JS, Epstein JI, Yang MB, Chasin M, Brem H: Interstitial chemotherapy of the 9L gliosarcoma: controlled release polymers for drug delivery in the brain. Cancer Res 53:329-333, 1993.
15. Chasin M, Lewis D, Langer R: Polyanhydrides for controlled drug delivery. Biopharm Manufact 1:33-46, 1988.
16. Domb A, Langer R: Polyanhydrides. I. Preparation of high molecular weight polyanhydrides. J Exp Med 112: 509-531, 1987.
17. Williams JA, Edwards JA, Dillehay LE: Quantitative comparison of radiolabeled antibody therapy and external beam radiotherapy in the treatment of human glioma xenografts. Int J Radiat Oncol Biol Phys 24: 111-117, 1992.
18. Mayer R, Dillehay LE, Shao Y, Song S, Zhan YG, Bartholomew RM, Williams JR: A new method for determining dose rate distribution from radioimmunotherapy using radiochromic medium. Int J Radiat Oncol Biol Phy 28:505-513, 1993.
19. Glanz SA: Primer of Biostatistics. New York: McGraw Hill Inc, 1992.
20. Wu M, Tamado J, Brem H, Langer R: In vivo versus in vitro degradation of controlled release polymers for intracranial surgical therapy. J Biomed Mater Res 28: 387-395, 1994.
21. Brown JM: SR 4233 (Tirapazamine): A new anticancer drug exploiting hypoxia in solid tumors. Br J Cancer 67:1163-1170, 1993.
22. Zeman EM, Hirst VK, Lemmon MJ, Brown JM: Enhancement of radiation-induced tumor cell killing by the hypoxic cell toxin SR 4233. Radiother Oncol 12: 209-218, 1988.
23. Zeman EM, Brown JM, Lemmon MJ, Hirst VK, Lee WW: SR 4233: A new bioreductive agent with high selective toxicity for hypoxic cells. Int J Radiat Oncol Biol Phys 12:1239-1242, 1986.
24. Thomlinson RH, Gray LH: The histological structure of some human lung cancers and possible implications for radiotherapy. Br J Cancer 9:539-549, 1955.
25. Hockel M, Vordan B, Schlenger K, Knapstein G: Tumor oxygenation: A new predictive parameter in locally advanced cancer of the uterine cervix. Gyn One 51:141-149, 1993.
26. Phillips T, Wasserman TH, Stetz J, Brady L: Clinical trials of hypoxic cell sensitizers. Int J Radiat Oncol Biol Phys 8:327-334, 1982.
27. Overgaard J, Hansen HS, Lindelov B, Overgaard M, Jorgenson K, Rusmusson B: Nimorazole as a hypoxic radiosensitizer in the treatment of supraglottic larynx and pharyngeal carcinoma. First report from the Danish Head and Neck Cancer Study (DAHANCA) protocol 5-85. Radiother Oncol Suppl 20:143-149, 1991.
28. Lee DJ, Cosmatos D, Marcial VA, Fu KK, Rotman M, Cooper JS, Ortiz HG, Beitler JJ, Abrams RA, Curran WJ, Coleman CN, Wasserman TH: Results of an RTOG Phase III Trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas. Int J Radiat Oncol Biol Phys 32:567-576, 1995.
29. Dorie MJ, Brown JM: Comparison of the enhancement of tumor responses to fractionated irradiation by SR 4233 (Tirapazamine) and by nicotinamide with carbogen. Int J Radiat Oncol Biol Phys 28:145-150, 1993.
30. Kim IH, Brown JM: Reoxygenation and rehypoxiation in the SCCVII mouse tumor. Int J Radiat Oncol Biol Phys 29:493-497, 1994.
31. Brem H, Piantadosi S, Burger PC, Walker M, Selker R, Vick NA, Black K, Sisti M, Brem S, Mohr G, Muller P, Morawetz R, Schold SC: Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. Lancet 345:1008-1012, 1995.
32. Brem H, Edwend MG, Plantadosi S, Greenhoot J, Burger PC, Sisti M: The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: Phase I trial. J Neurooncol 26:111-123, 1995.
33. Brem SS, Sagzag D, Tsanaclis AMC, Gately S, Elbouky MP, Brien SE: Inhibition of angiogenesis and tumor growth in the brain. Am J Pathol 137:1121-1142, 1990.
34. Edwend MG, Williams JA, Tabassi K, Tyler BM, Babel KM, Anderson RC, Pinn ML, Brat DJ, Brem H: Local delivery of chemotherapy and concurrent external beam radiotherapy prolongs survival in metastatic brain tumor models. Cancer Res 56:5217-5323, 1966.
35. Judy KD, Olivi A, Buahin KG, Epstein JI, Colvin OM, Brem H: Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas. J Neurosurg 82:481-486.
36. Walker KA, Cahan MA, Gur A, Tyler B, Hilton J, Colvin OM, Burger PC, Domb A, Brem H: Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma. Cancer Res 54: 2207-2212, 1995.
37. Lin PS, Ho KC: New cytotoxic mechanism of the bioreductive agent tirapazamine (SR 4233) mediated by forming complex with copper. Radiat Oncol Invest 4: 211-220, 1997.
38. Olivi A, Edwend MG, Utsuki T, Tyler B, Domb AJ, Brat DJ, Brem H: Interstitial delivery of carboplatin via biodegradable polymers is effective against experimental glioma in the rat. Cancer Chemother Pharmacol 39: 90-96, 1996.